MeSH term | MeSH ID | Detail |
---|---|---|
Lymphoma, Large-Cell, Anaplastic | D017728 | 3 associated lipids |
Acne Vulgaris | D000152 | 35 associated lipids |
Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
Lung Neoplasms | D008175 | 171 associated lipids |
13-cis-retinoic acid,isotretinoin is a lipid of Prenol Lipids (PR) class. 13-cis-retinoic acid,isotretinoin is associated with abnormalities such as Dermatitis, Phototoxic. The involved functions are known as Regulation, Pigment, chromophore, Light absorption and Pupil constriction. 13-cis-retinoic acid,isotretinoin often locates in Neurosecretory Systems. The associated genes with 13-cis-retinoic acid,Isotretinoin are melanopsin.
To understand associated biological information of 13-cis-retinoic acid,Isotretinoin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
13-cis-retinoic acid,Isotretinoin is suspected in Dermatitis, Phototoxic and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with 13-cis-retinoic acid,Isotretinoin
MeSH term | MeSH ID | Detail |
---|---|---|
Lymphoma, Large-Cell, Anaplastic | D017728 | 3 associated lipids |
Acne Vulgaris | D000152 | 35 associated lipids |
Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
Lung Neoplasms | D008175 | 171 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Sharquie KE et al. | The therapeutic role of isotretinoin in the management of Behçet's disease: a single-blinded, controlled therapeutic study. | 2013 | J Drugs Dermatol | pmid:23652909 |
Elpern DJ | Isotretinoin and one patient's teary eyes: "please listen or I'll cry". | 2013 | Int. J. Dermatol. | pmid:23679883 |
Stobaugh DJ et al. | Alleged isotretinoin-associated inflammatory bowel disease: disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System. | 2013 | J. Am. Acad. Dermatol. | pmid:23683730 |
Ali FR and Al-Niaimi F | Acne vulgaris. | 2013 | Br J Hosp Med (Lond) | pmid:23656986 |
Dawson AL and Dellavalle RP | Acne vulgaris. | 2013 | BMJ | pmid:23657180 |
Moreno L et al. | About the benefits of immunotherapy for high-risk neuroblastoma. | 2013 | J. Clin. Oncol. | pmid:23295791 |
Stobaugh DJ et al. | Concomitant antibiotic usage does not augment the risk of inflammatory bowel disease with isotretinoin treatment for acne: a review of the Food and Drug Administration Adverse Event Reporting System. | 2013 | Eur. J. Clin. Pharmacol. | pmid:23052415 |
Alhusayen RO et al. | Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study. | 2013 | J. Invest. Dermatol. | pmid:23096714 |
Rademaker M | Isotretinoin: dose, duration and relapse. What does 30 years of usage tell us? | 2013 | Australas. J. Dermatol. | pmid:23013115 |
Raza K et al. | Nanocolloidal carriers of isotretinoin: antimicrobial activity against Propionibacterium acnes and dermatokinetic modeling. | 2013 | Mol. Pharm. | pmid:23544848 |
Balakirski G et al. | [Morbihan disease as a special form of rosacea: review of pathogenesis and new therapeutic options]. | 2013 | Hautarzt | pmid:24201653 |
Baratli J and Megahed M | [Lupoid perioral dermatitis as a special form of perioral dermatitis: review of pathogenesis and new therapeutic options]. | 2013 | Hautarzt | pmid:24201654 |
McIntee TJ and Bruckner AL | Challenges in optimizing isotretinoin use for acne vulgaris. | 2013 | JAMA Dermatol | pmid:24172999 |
Blasiak RC et al. | High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris. | 2013 | JAMA Dermatol | pmid:24173086 |
Petruzzi M et al. | Topical retinoids in oral lichen planus treatment: an overview. | 2013 | Dermatology (Basel) | pmid:23548887 |
Melnik BC and Schmitz G | Are therapeutic effects of antiacne agents mediated by activation of FoxO1 and inhibition of mTORC1? | 2013 | Exp. Dermatol. | pmid:23800068 |
BaÅŸak PY et al. | The effects of systemic isotretinoin and antibiotic therapy on the microbial floras in patients with acne vulgaris. | 2013 | J Eur Acad Dermatol Venereol | pmid:22239608 |
Cakir GA et al. | Isotretinoin treatment in nodulocystic acne with and without polycystic ovary syndrome: efficacy and determinants of relapse. | 2013 | Int. J. Dermatol. | pmid:22998438 |
Tankurt E et al. | Esophageal ulcers: a possible adverse effect of isotretinoin. | 2013 | Turk J Gastroenterol | pmid:24623299 |
Gan EY et al. | Isotretinoin is safe and efficacious in Asians with acne vulgaris. | 2013 | J Dermatolog Treat | pmid:22390469 |